MedPath

A Multi-center, Prospective, Randomized Study With PriMatrix and PriMatrix Ag for the Treatment of Venous Leg Ulcers

Not Applicable
Terminated
Conditions
Venous Stasis Ulcer
Interventions
Device: PriMatrix
Device: PriMatrix Ag
Procedure: moist wound therapy
Registration Number
NCT01612806
Lead Sponsor
Integra LifeSciences Corporation
Brief Summary

To evaluate the effectiveness of PriMatrix, PriMatrix Ag, and Standard of Care in the treatment of venous leg ulcers (VLUs).

Detailed Description

Healing percentages

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
31
Inclusion Criteria
  • Men or women ≥ 18 years of age
  • Ankle-brachial index (ABI) > 0.80
  • Study wound 2-64 cm2 surface area
  • Wound does not exhibit a greater than 50% reduction in surface area during the screening period
Exclusion Criteria
  • Suspected or confirmed signs/symptoms of wound infection
  • Hypersensitivity to bovine collagen
  • Body Mass Index (BMI) ≥ 45

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PriMatrixPriMatrixPriMatrix Dermal Repair Scaffold
PriMatrix Agmoist wound therapyPriMatrix Ag Antimicrobial Dermal Repair Scaffold
PriMatrix AgPriMatrix AgPriMatrix Ag Antimicrobial Dermal Repair Scaffold
PriMatrixmoist wound therapyPriMatrix Dermal Repair Scaffold
Standard of Caremoist wound therapyStandard of Care Moist Wound Therapy
Primary Outcome Measures
NameTimeMethod
Percent of VLUs healed by week 12 post-randomization12 weeks
Secondary Outcome Measures
NameTimeMethod
Cost of treatment12 weeks

Trial Locations

Locations (5)

Caribbean Clinical Trials

🇵🇷

San Juan, Puerto Rico

Dr. Pila Metropolitan Hospital Wound Healing Center

🇵🇷

Ponce, Puerto Rico

Doctors' Center Hospital of San Juan

🇵🇷

San Juan, Puerto Rico

Wound and Ulcer Care Clinic of San Juan

🇵🇷

San Juan, Puerto Rico

Wilma N. Vazquez Hospital

🇵🇷

Vega Baja, Puerto Rico

© Copyright 2025. All Rights Reserved by MedPath